Skip to content
RegionSub-Saharan Africa

HighI Geo-Economics & Chokepoints16 September 2026, Wednesday

Ebola outbreak in DR Congo reaches 7,404 confirmed cases and 3,577 deaths, with Ituri the centre on 5,751 cases

The Democratic Republic of the Congo reported a total of 7,404 confirmed Ebola cases and 3,577 deaths on 16 September; 59 new cases and 32 deaths were added in a day. The outbreak stems from the Bundibugyo strain and affects 62 of 167 health zones across seven provinces.

BUNIA

According to the European Centre for Disease Prevention and Control (ECDC) update of 16 September 2026, the total number of confirmed cases in DR Congo reached 7,404 and the death toll 3,577; 59 new cases and 32 new deaths were added since 15 September. There are 930 patients in isolation, 1,776 people have recovered and 87.4% of identified contacts are under follow-up. By province, Ituri leads with 5,751 cases and 2,622 deaths (28 of its 36 health zones affected), followed by North Kivu with 1,323 cases and 821 deaths. Haut-Uele reported 290 cases, Tshopo 29, Bas-Uele 7, South Kivu 3 and Sud Ubangi 1. The outbreak in Uganda ended on 25 August 2026; 20 cases had been seen there between May and June.

In the World Health Organization Director-General's statement at the press briefing of 16 September, the figures were given in rounded form: more than 7,200 cases and more than 3,500 deaths across seven provinces. According to the same statement, about 300 new cases and 160 deaths were reported in the past week, most of them from Ituri. The difference between the two sources comes from the data cut-off date; the ECDC provides the more current and detailed series.

According to the WHO, transmission in Ituri is falling but from a high level; in North Kivu, meanwhile, the weekly case count nearly doubled within two weeks from 100 to more than 200. No new cases have been seen in South Kivu since May. The agent of the outbreak is the Bundibugyo ebolavirus; because the currently approved treatments and vaccines target the Zaire strain, the response is harder. The WHO said trials of treatment and post-exposure prophylaxis were accelerating, that vaccine trials were expected to begin in the coming weeks, and that donor support was needed to fully fund the government's response plan and the wider humanitarian plan.

Talay assessment

Bottom line

The outbreak is slowing in Ituri while doubling the weekly case count in North Kivu within two weeks; what matters, in other words, is not the overall trend but the geographical shift. Because the approved vaccine and treatment target the Zaire strain, the classic toolkit of the response is left ineffective and dependence on trials is created. The most likely direction is for case numbers to keep rising at a decreasing rate, with the funding shortfall becoming the critical variable.

Likely effects

  • DR Congo mining regionsNegative1–6 months

    With 62 health zones affected in Ituri and North Kivu, labour mobility and field logistics are constrained at the gold and mining sites in the same geography.

  • Risk of regional spreadNegativeWeeks

    Although the end of the Ugandan outbreak on 25 August shows control is possible in neighbouring countries, the acceleration in North Kivu carries cross-border risk.

  • Humanitarian fundingNegativeWeeks

    The WHO's appeal to donors makes plain that the government response plan and the wider humanitarian plan are not currently fully funded.

Possibilities, ranked

  1. 1
    Slowing but continuing spread55%

    The decline in Ituri continues, the rise in North Kivu offsets it and the total case count keeps rising at a slower pace.

    Watch: Whether daily new cases fall below 59 in ECDC updates.

  2. 2
    A surge in North Kivu30%

    The doubling trend in North Kivu continues and the centre of gravity of the outbreak shifts to that province.

    Watch: Weekly case numbers in North Kivu rising clearly above 200.

  3. 3
    Rapid control through a vaccine trial15%

    Vaccine trials against the Bundibugyo strain begin and response capacity is markedly strengthened.

    Watch: The WHO announcing that vaccine trials have started in the field.

Probabilities are calibrated judgement based on the sources, not measurement, and are revised as new information arrives. Not investment advice.

Market reaction

Indicators affected

  • Ituri field logistics constrained
  • Health response funding shortfall
  • Regional travel tightening

Sources

  1. ECDC — Ebola outbreak in the Democratic Republic of the Congo, update
  2. WHO — Director-General's opening remarks at the media briefing, 16 September 2026